Biomarkers: From Standardization to Performance

Open access

Biomarkers: From Standardization to Performance

Majkić-Singh N. Society of Medical Biochemists of Serbia Activity. Journal of Medical Biochemistry 2011; 30: 149-154.

Bossuyt MMP. Defining biomarker performance and clinical validity. Journal of Medical Biochemistry 2011; 30: 193-200.

Gillery P. Nonenzymatic post-translational modification derived products (PTMDPS): New biomarkers of protein aging. Journal of Medical Biochemistry 2011; 30: 201-206.

Sypniewska G, Bergmann K, Krintus M, Kozinski M, Kubica J. How do apolipoproteins ApoB and ApoA-I perform in patients with acute coronary syndromes. Journal of Medical Biochemistry 2011; 30: 237-243.

Aslan D. Biomarkers for diabetes complications: The results of several clinical studies. Journal of Medical Biochemistry 2011; 30: 207-212.

Janković M. Glycans as biomarkers: Status and perspectives. Journal of Medical Biochemistry 2011; 30: 213-223.

Journal of Medical Biochemistry

The Journal of Society of Medical Biochemists of Serbia

Journal Information


IMPACT FACTOR 2017: 1.378
5-year IMPACT FACTOR: 0.704



CiteScore 2017: 1.05

SCImago Journal Rank (SJR) 2017: 0.307
Source Normalized Impact per Paper (SNIP) 2017: 0.532

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 95 94 6
PDF Downloads 36 36 3